|
|
Volumn 33, Issue 5, 2015, Pages 438-
|
|
Biogen's early Alzheimer's data raise hopes, some eyebrows
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADUCANUMAB;
MONOCLONAL ANTIBODY;
ALZHEIMER DISEASE;
DRUG INDUSTRY;
HUMAN;
PHASE 1 CLINICAL TRIAL (TOPIC);
ALZHEIMER DISEASE;
ANTIBODIES, MONOCLONAL, HUMANIZED;
CLINICAL TRIALS, PHASE I AS TOPIC;
DRUG INDUSTRY;
HUMANS;
|
|
EID: 84986281474
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0515-438 Document Type: Note |
|
Times cited : (18)
|
|
References (0)
|